Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2020-09-03 | 2020-09-17 | 123735 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2021-10-21 | 2022-10-18 | 147717 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2022-01-20 | 2022-02-17 | 153186 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2022-06-16 | 2022-10-29 | 162858 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2024-01-11 | 2025-11-06 | 215707 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2024-02-22 | 2025-06-21 | 220261 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2025-11-13 | 2025-12-04 | 271782 |
| TEVA-SELEGILINE | 5MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103814 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-30 | 42658 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2020-04-10 | 2020-09-03 | 111846 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2020-06-18 | 2020-07-23 | 118244 |
| TEVA-SERTRALINE | 25MG | CAPSULE | Resolved | 2020-11-12 | 2021-03-18 | 128330 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2020-11-12 | 2021-03-18 | 128333 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2020-11-12 | 2021-03-18 | 128336 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-01 | 136323 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2021-04-15 | 2021-04-21 | 137547 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2022-10-28 | 2023-01-18 | 173000 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2023-04-27 | 2023-07-14 | 190746 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2023-06-19 | 2023-07-05 | 195449 |
| TEVA-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-07-04 | 2023-08-18 | 197218 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |